Market Overview

McNicoll Lewis Vlak Downgrades Alnylam Pharmaceuticals, Inc. to Hold, Raises PT to $27.50

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for ALNY

DateFirmActionFromTo
May 2016Leerink SwannMaintainsOutperform
Apr 2016Chardan CapitalInitiates Coverage onBuy
Mar 2016JP MorganUpgradesNeutralOverweight

View More Analyst Ratings for ALNY
View the Latest Analyst Ratings

Posted-In: News Downgrades Analyst Ratings

 

Related Articles (ALNY)